Finally Cd45 For Women [6dnToG9g]

High-Quality Finally Cd45 For Women [6dnToG9g] Monoclonal Antibody for Canine Research

Our Finally Cd45 For Women [6dnToG9g] Monoclonal Antibody is a highly specialized reagent designed for canine research. This monoclonal antibody recognizes the canine homologue of Finally Cd45 For Women [6dnToG9g], also known as Leukocyte Common Antigen, providing a crucial tool for analyzing leukocytes. With exceptional specificity and sensitivity, it is ideal for various immunophenotyping applications.

• Species Reactivity: Canine
• Source: Mouse Monoclonal

Key Product Properties and Specifications

This monoclonal antibody, cataloged as VeteMAbXXX, is derived from a mouse monoclonal clone, CA12.10C12. It is expressed on the cell membrane of normal and neoplastic leukocytes, excluding erythrocytes and plasma cells. The antigen used in the production of this antibody is proprietary, ensuring a high level of quality and consistency.

• Antigen: Proprietary
• Positive Control: Tonsil

These specifications make it a reliable choice for researchers seeking accurate and reproducible results.

Applications and Benefits

The Finally Cd45 For Women [6dnToG9g] Monoclonal Antibody is a versatile tool for a wide range of research applications, particularly in the study of lymphoma, leukemias, and other canine hematological disorders. It aids in the identification and characterization of leukocytes, allowing for a better understanding of canine immune responses. This antibody is also beneficial for clinical diagnostics, as it can help identify specific leukocyte populations, leading to improved disease management.

• Target Audience: Veterinary researchers, clinical pathologists, and immunologists
• Practical Uses: Immunophenotyping, disease diagnosis, and immune response analysis

With its precise reactivity and robust performance, this monoclonal antibody is an essential resource for any research or clinical setting focused on canine leukocyte analysis.